Johnson And Johnson Revenue per Employee (JNJ), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Johnson and Johnson  (NYSE: JNJ)
 

Johnson And Johnson's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 5.86% in the third quarter 2026, year on year to cumulative value of $99,335 million, Johnson And Johnson's revenue per employee grew on a trailing twelve months basis to $ 705,504. The productivity of Johnson And Johnson's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 126 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1250, from total ranking in previous quarter at 1510. Johnson And Johnson has 140,800 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

JNJ Revenue per Employee (Sep 27 2026)
III. Quarter		 (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 28 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter
Y / Y Revenue Change 5.86 % 6.6 % 9.91 % 9.08 % 6.77 %
Sales per Employee (TTM) $ 705,504 695,518 684,389 668,984 654,467
JNJ's Total Ranking # 1250 # 1510 # 1291 # 1301 # 1320
Seq. Revenue Change 0.35 % 5.19 % -2.04 % 2.38 % 1.05 %

JNJ Company Profile >> Back to JNJ Efficiency Comparisons >> Compare JNJ Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 84
Healthcare Sector # 127
Overall Market # 1250

Revenue per Employee Statistics
High Average Low
$ 695,518 $ 529,374 $ 358,764
(Jun 28 2026)   (Dec. 30. 2005)



Financial Statements
Johnson And Johnson's Revenue MRQ $ 25,399 Millions Visit JNJ's Income Statement
Johnson And Johnson's Revenues TTM $ 99,335 Millions Visit JNJ's aggregate revenue growth
What are JNJ's Sales? Visit JNJ's Sales by Segment




Other Ratios
Johnson And Johnson's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
JNJ's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for JNJ's Competitors
Revenue per Employee for JNJ's Suppliers
Revenue per Employee for JNJ's Customers

You may also want to know
JNJ's Sales Growth Rates JNJ's Pe Price to earnings ratio JNJ's Receivables Turnover Ratio JNJ's Stock Quote
JNJ's Net Income Growth Rates JNJ's Ps Price to Sales ratio JNJ's Sales per Employee JNJ's Asset Turnover Ratio
JNJ's Net Margin JNJ's Pb Price to Book ratio JNJ's Financial Strength Ratios JNJ's Dividend Payout Ratio
Date modified: 2026-10-22T03:32:26+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 27 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 27 2026Number of Employees Sep 27 2026
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
3m Company  417,305.79 $ 25,247.000  Million 60,500 
Cryo cell International Inc   409,559.89 $ 31.127  Million 76 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.